- Home
- ADVM vs EBMT Comparison
ADVM vs EBMT Comparison
Compare ADVM & EBMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADVM
- EBMT
- Stock Information
- Founded
- ADVM 2006
- EBMT 1922
- Country
- ADVM United States
- EBMT United States
- Employees
- ADVM N/A
- EBMT N/A
- Industry
- ADVM Biotechnology: Biological Products (No Diagnostic Substances)
- EBMT Major Banks
- Sector
- ADVM Health Care
- EBMT Finance
- Exchange
- ADVM Nasdaq
- EBMT Nasdaq
- Market Cap
- ADVM 119.6M
- EBMT 139.5M
- IPO Year
- ADVM 2014
- EBMT N/A
- Fundamental
- Price
- ADVM $4.74
- EBMT $15.27
- Analyst Decision
- ADVM Strong Buy
- EBMT
- Analyst Count
- ADVM 6
- EBMT 0
- Target Price
- ADVM $27.83
- EBMT N/A
- AVG Volume (30 Days)
- ADVM 226.5K
- EBMT 14.5K
- Earning Date
- ADVM 11-04-2024
- EBMT 01-21-2025
- Dividend Yield
- ADVM N/A
- EBMT 3.76%
- EPS Growth
- ADVM N/A
- EBMT N/A
- EPS
- ADVM N/A
- EBMT 1.09
- Revenue
- ADVM $1,000,000.00
- EBMT $80,038,000.00
- Revenue This Year
- ADVM N/A
- EBMT N/A
- Revenue Next Year
- ADVM $1,342.84
- EBMT $8.40
- P/E Ratio
- ADVM N/A
- EBMT $13.98
- Revenue Growth
- ADVM N/A
- EBMT N/A
- 52 Week Low
- ADVM $4.59
- EBMT $12.32
- 52 Week High
- ADVM $29.70
- EBMT $17.65
- Technical
- Relative Strength Index (RSI)
- ADVM 26.02
- EBMT 24.11
- Support Level
- ADVM $4.59
- EBMT $15.06
- Resistance Level
- ADVM $4.89
- EBMT $17.05
- Average True Range (ATR)
- ADVM 0.31
- EBMT 0.43
- MACD
- ADVM -0.06
- EBMT -0.23
- Stochastic Oscillator
- ADVM 9.80
- EBMT 8.01
About ADVM Adverum Biotechnologies Inc.
Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license, research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single, in-office intravitreal (IVT) injection gene therapy designed to deliver long-term durable levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) injections. It has one segment developing and commercializing gene therapeutics.
About EBMT Eagle Bancorp Montana Inc.
Eagle Bancorp Montana Inc operates as a bank holding company. It provides loan and deposit services. The company focuses on residential loans, commercial real estate loans, commercial loans, consumer loans, and home equity loan products. The bank also offers deposit accounts which include checking, savings, money market, individual retirement accounts, and certificates of deposit accounts. It is a diversified lender with a focus on residential mortgage loans, commercial real estate mortgage loans, commercial business loans, agricultural loans, and second mortgage/home equity loan products.